Results 141 to 150 of about 6,488,856 (287)

Kaempferol Attenuates Myocardial Ischemia–Reperfusion Injury by Suppressing Ferroptosis via the KEAP1–Nrf2–GPX4 Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Myocardial ischemia/reperfusion (I/R) injury is characterized by cardiomyocyte death, excessive oxidative stress, inflammation, and ferroptosis, which collectively limit the efficacy of reperfusion therapy. In this study, we investigated whether kaempferol (KAE), a natural flavonol with antioxidative and antiinflammatory properties, could ...
Yan‐Bo Zhao, Ling‐Ling Sun, Xiao‐Hua Shen, Min Wang, Mei‐Hui Wang, Lu‐Lu Liu, Kai Zhang   +6 more
wiley   +1 more source

Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention Society

Percutaneous techniques to treat obstructive coronary artery disease continue to evolve and the evidence base informing our practice is shared and summarised in international guidelines.
Purcell, Ian, Abouelasaad, Mohamed, Banerjee, Shrilla, Banning, Adrian, Mamas, Mamas, Appleby, Clare, O’Kane, Peter, Sharma, Vinoda, Curzen, Nick, Kinnaird, Tim, Gudde, Ellie, Routledge, Helen, Carson, Sarah, Aggarwal, Suneil, Clesham, Gerald, Spratt, James, McKenzie, Dan, Hildick-Smith, David, Nolan, James, Muir, Douglas F, Al-Lamee, Rasha, Zaman, Azfar, Irving, John, McGrath, Samuel   +23 more
core   +1 more source

Circulating Omega‐3 Fatty Acids and Cardiometabolic Outcomes: A Systematic Review of Publications From UK Biobank

Lipids, EarlyView.
ABSTRACT Studies have shown that omega‐3 fatty acids may protect against cardiovascular diseases (CVDs) and related metabolic conditions. UK Biobank is a large cohort study that includes data on plasma omega‐3 fatty acids at study entry and health outcomes during the follow‐up period.
Warda Tul Firdous, Philip C. Calder
wiley   +1 more source

The Role and Assessment of Lipid Profile in Patients With a Chronic Total Coronary Occlusion

Lipids, EarlyView.
This review summarized evidence on lipid profiles in CTO patients, non‐CTO patients, and healthy individuals, and examined the reported associations between lipid parameters, collateral channel formation, and clinical outcomes. Several key findings emerged from the present study.
Karol Sadowski, Dominika Tomkiel, Roel Hoek, Ruben W. de Winter, Nick S. Nurmohamed, Bimmer E. P. M. Claessen, Niels J. Verouden, Alexander Nap, Sebastiaan A. Kleijn, Mariusz Tomaniak, Yvemarie B. O. Somsen, Paul Knaapen   +11 more
wiley   +1 more source

The impact of primary percutaneous coronary intervention timing on prognosis in STEMI patients. [PDF]

Clin Med (Lond)
Zhou L, Si J, Yi M, Xiao K, Sun L, Zhang H, Sun J, Fan Z, Liu Z, Gao J, Pi L, Zhang Y, Li J.   +12 more
europepmc   +1 more source

Primary Percutaneous Coronary Intervention in the Very Elderly: A Realistic Intervention?

Journal of the Royal College of Physicians of Edinburgh, 2021
Sajeel, Ahmed, Raheel, Ahmed, Honey, Thomas   +2 more
openaire   +2 more sources

The Application of Telemedicine in Surgery

Med Research, EarlyView.
This figure provides an overview of the content presented in this article. Telemedicine is integrated throughout the entire surgical workflow, with distinct applications across the preoperative, intraoperative, and postoperative phases. These applications are enabled by a suite of supporting technologies, while the associated implementation challenges ...
Yufan Yang, Chang Liu, Xue Sun, Yiting Wang, Minghui Zhao, Shuya Jiang, Haoling Zhang, Wangzheqi Zhang, Wenwen Shi   +8 more
wiley   +1 more source

Relationship Between Admitting Diagnosis, Use of Primary Percutaneous Coronary Intervention, and Survival for Patients Who Develop a STEMI While Hospitalized. [PDF]

Am J Cardiol
Lian G, Patel RC, Stouffer GA.
europepmc   +1 more source

Influence of sex on outcomes after percutaneous coronary intervention in patients over 75 years of age with coronary heart disease

, 2014
Yuqi Liu,* Xin Hu,* Qiao Xue, Yusheng Zhao, Yu Wang, Lei Gao Institute of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, People’s Republic of China *These authors contributed equally to this work Background: This study aimed ...
Liu Y, Hu X, Xue Q, Gao L, Wang Y, Zhao Y   +5 more
core  

Current status and future perspectives of platelet function‐guided precision antiplatelet therapy for patients with cerebral infarction

Neuroprotection, EarlyView.
Antiplatelet agents target the cyclooxygenase‐1 (COX‐1)/thromboxane A2 (TXA2) and adenosine diphosphate (ADP)‐P2Y12 (cytochrome P450 2C19 [CYP2C19]‐metabolized) platelet activation pathways, resulting in either drug resistance or over‐inhibition. The individualized therapeutic window balances ischemic risk (triggered by high on‐treatment platelet ...
Guoliang Zhu, Xiaoling Chen, Xinyi Huang, Quandan Tan, Qing Cao, Yali Yang, Yapeng Lin, Jie Yang   +7 more
wiley   +1 more source